New York A09501 prohibits insurers from denying coverage or increasing rates based on gender-affirming care-related drugs and outlines procedures for.
New York A09501 amends the insurance law and the general business law to ensure that professional liability insurance insurers cannot deny coverage or increase rates solely based on the legal use or prescription of certain gender-affirming care-related drugs. The bill also prescribes procedures for warrants issued in other jurisdictions for electronic data related to legally protected health activities.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.